UNITED ~~STATES~~ ~~SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549~~STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of ~~the Securities Exchange Act~~ of ~~1934~~

~~Date~~the Securities ofExchange ~~Report~~Act ~~(Date~~ of ~~earliest event reported) October 29, 2007~~1934

~~WIFIMED~~Date ~~HOLDINGS~~of Report ~~COMPANY, INC.~~ (~~Exact~~Date ~~name~~ of ~~registrant~~earliest asevent ~~specified~~reported) inMarch ~~its~~13, ~~charter)~~2009

WIFIMED HOLDINGS COMPANY, INC.

(Exact name of registrant as specified in its charter)

Nevada		0-49707		58-2412118
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

2000 River Edge Parkway, Suite GL 100A		30328
2000 RiverEdge Parkway Suite GL 100A Atlanta, Georgia		30328
Atlanta, GA
(Address of principal executive offices)		(Zip Code)

Registrant's telephone number, including area code: 770-919-7220

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[o ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [o ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [o ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [o ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8 3.0102 - ~~Other~~Unregistered ~~Events~~Sales of Equity Securities

~~Letter~~On March 13, the Company concluded three transactions that resulted in the sale of ~~Intent~~unregistered securities. About a month earlier, the Company concluded a confidential settlement agreement that also resulted in the sale of unregistered securities. These transactions are not related to one another, and none of them is deemed by the Company to be a material definitive agreement within the meaning of Section 1 of Form 8-K. However, they do in aggregate exceed 5% of the number of shares outstanding of the class of equity securities sold, and therefore trigger, under Item 3.02(b), the obligation to report such sales prior to the filing of the Company’s 10-K report.

OnThe ~~October~~Company 29entered into an Amendment to Employment Agreement with its president and CEO, ~~2007~~Gregory D. Vacca that resulted in the award and delivery to Mr. Vacca of five million (5,000,000) shares ~~Wifimed~~of ~~Holdings~~the Company’s common stock on March 13, ~~Inc~~2009. Pursuant to a proposal by Mr. Vacca made to (~~"we" or~~and ~~"our"~~accepted in principle by) ~~entered~~the ~~into~~Company’s aBoard of ~~letter~~Directors (the “Board”) on or about February 9, 2009, Mr. Vacca and the Company agreed that Mr. Vacca would be paid 2,500,000 shares of ~~intent~~unregistered common stock in exchange for his forgiveness of $25,000 ~~which~~due isbut ~~attached~~then-unpaid asin compensation ~~Exhibit~~owed 10pursuant to the terms of the employment agreement entered into by the Company and Mr.1 ~~hereto~~Vacca effective on or about October 15, 2007. Mr. Vacca also agreed, in recognition of the economic environment and ~~incorporated~~current ~~herein~~financial circumstances, and as part of an effort to demonstrate his commitment to the Company, to reduce his claim for back pay, including bonus pay, by ~~reference~~an additional $50,000 ~~with~~for ~~CyberMedx~~no ~~Medical~~additional consideration. In ~~Systems~~addition, ~~LLC~~the ~~("Cybermedx")~~Company also agreed to provide Mr. Vacca 2,500,000 shares of unregistered common stock in exchange for his forgiveness of $25,000 debt in connection with the non-payment by the Company and its subsidiaries of reimbursable business expenses.

~~Cybermedx~~The Company and its financial advisor, Principal ~~founded~~Capital inGroup, ~~1996~~Inc. (“PCG”), isentered ainto ~~privately~~an ~~held~~amendment ~~California~~on ~~based~~March ~~developer~~13, 2009 ofto ~~patient~~their ~~data~~existing ~~management~~engagement ~~products~~agreement ~~for~~pursuant to which the ~~hospital,~~Company ~~home~~paid ~~care~~5 million ~~and~~shares ~~nursing~~of ~~home~~the ~~industries~~Company’s common stock to PCG. The ~~Cybermedx~~Company ~~products~~and PCG ~~are~~agreed ~~used~~to amend their agreement to ~~increase~~provide ~~productivity~~that 2,500,000 ~~reduce~~of ~~cost,~~such ~~improve~~shares would ~~efficiency~~be deemed the final installment of the retainer for expenses, and ~~extend~~the remaining 2,500,000 of such shares would be deemed a credit (valued at $0.03 per share) against certain cash payments due to PCG in the ~~operational~~event ~~life~~that ~~expectancy~~certain funding oftransactions ~~existing~~close. Pursuant ~~patient~~to ~~monitoring~~the ~~and~~amendment, ~~therapy~~if ~~delivery~~no qualified ~~devices~~funding transactions close within six months, those shares will be forfeited.

~~Cybermedx~~Also ~~founder~~effective March 13, ~~Ronald~~2009, R.the Company ~~Barnett~~paid 2,750,000 ~~designed~~shares of the ~~central~~Company’s ~~station~~common ~~data~~stock ~~management~~to ~~concept~~Mr. ofSteven ~~Open~~K. Eckert ~~Architecture~~in ~~Interface~~two related transactions pursuant to which (~~OAI~~a) ~~technology.~~the ~~Its~~Company’s wholly-owned ~~initial~~subsidiary ~~product~~EncounterPRO Healthcare Resources, ~~CyberStat~~Inc. (“EHRI”) purchased certain assets and acquired certain obligations of Clinical Solutions, Inc., isand a(b) ~~hardwired~~Mr. ~~networked~~Eckert ~~pulse~~and ~~oximeter~~EHRI ~~data~~entered ~~management~~into ~~system~~an ~~that~~amendment isto ~~used~~a atpromissory ~~Baylor~~note evidencing ~~University~~a ~~Medical~~debt ~~Center~~of inapproximately ~~Dallas~~$53,000 owed by EHRI to Mr. In Eckert. Pursuant ~~2001~~to the terms of the amendment, ~~Cybermedx~~the ~~introduced~~maturity date of the ~~CyberTrac~~promissory ~~wireless~~note ~~asset~~is ~~tracking~~extended ~~concept~~for about five months, ~~utilizing~~and ~~OEM~~the ~~technology~~amounts ~~for~~owed ~~proof~~by EHRI ofto ~~concept~~Mr. ~~CyberTrac~~Eckert ~~was~~are ~~delivered~~reduced (pursuant to 14a ~~hospitals~~formula specified in the amendment) in the event that the Company’s stock appreciates in value in the 30 days prior to ~~track~~the ~~their~~new maturity date. The acquisition of assets and obligations ~~reduce~~of ~~loss. In~~Clinical ~~2004~~Solutions, anInc. ~~agreement~~does ~~was~~not ~~entered~~meet ~~into~~the ~~with~~standards ~~Micro~~of materiality ~~Technology~~for ~~Services~~purposes of Section 1 of Form 8-K, ~~Inc~~nor does such purchase qualify as the acquisition of a “business” under the guidance of Rule 11-01(d) of Regulation S-X. Moreover, even if such acquisition were deemed the acquisition of a “business,” the purchase does not approach meeting the 20% threshold requiring disclosure of financial statements pursuant to ~~offer~~Rule 3-05(b)(2) ~~CyberMedx~~of ~~product~~Regulation ~~software~~S-X. Mr. ~~and~~Eckert ~~hardware~~is ~~engineering~~the President and principal ~~manufacturing~~shareholder of Clinical Solutions, Inc.

~~Under~~The Company ~~the~~entered ~~terms~~into ofa ~~the~~confidential ~~letter~~settlement ofwith ~~intent,~~James weD. ~~would~~Copenhaver ~~acquire~~and Carolyn ~~all~~J. ofCopenhaver concerning the ~~outstanding~~Copenhavers’ ~~members'~~claims ~~interests~~against ofthe ~~Cybermedx~~Company effective inFebruary ~~exchange~~9, ~~for~~2009. Pursuant ~~shares~~to ofthe ~~our~~agreement, ~~common~~the ~~stock~~Company provided ~~valued~~three ~~at $4~~ million. ~~The~~unregistered ~~actual~~shares ~~number~~ of ~~shares~~the toCompany's becommon ~~issued~~stock ~~is subject~~ to ~~adjustment based on balance sheet changes as of the closing date~~Mr. Copenhaver, ~~The~~which ~~letter~~shares ofare ~~intent~~forfeitable ~~also~~under ~~provides~~certain ~~for~~conditions andescribed ~~additional~~in the ~~payout~~confidential ~~based~~settlement ~~on performance of certain objectives~~agreement.

~~Completion~~With respect to each of these transactions, the ~~proposed~~issuances ~~transaction~~of isthe ~~subject~~shares toin ~~approval~~were byexempt ~~the~~from ~~parties~~registration ofunder the aSecurities ~~definitive~~Act ~~acquisition~~of ~~agreement~~1933, ~~that~~as ~~will~~amended ~~include~~(the ~~various~~“Act”), ~~conditions~~pursuant ~~that~~to ~~are~~Section ~~set~~4(2) ~~forth~~the Act. inThe ~~the~~shares ~~letter~~issued ofhave ~~intent. There~~not ~~can~~been beregistered nounder ~~assurance~~the ~~that~~Act weand ~~will~~may not be offered ~~successful~~or sold in ~~negotiating~~the aUnited ~~definitive~~States ~~agreement~~absent registration or ~~achieving~~an ~~completion~~applicable exemption offrom ~~the~~registration ~~proposed transaction~~requirements.

~~Item~~The Company ~~9.01~~shall -furnish ~~Financial~~a ~~Statements~~copy ~~and~~of ~~Exhibits~~any omitted schedule or exhibit to the Commission upon request.

~~(c) Exhibits~~SIGNATURES

~~10.1~~ Pursuant -to ~~Letter~~the requirements of ~~Intent~~the ~~between~~Securities ~~Wifimed~~Exchange ~~Holdings~~Act ~~Company~~of 1934, ~~Inc.~~the Registrant ~~and~~has ~~CyberMedx~~duly ~~Medical~~caused ~~Systems,~~this ~~LLC~~report ~~dated~~to ~~October~~be ~~29,~~signed ~~2007~~on its behalf by the undersigned hereunto duly authorized.

SIGNATURES

Date:		March 18, 2009

		WiFiMed Holdings Company, Inc.

		Registrant

By:		/s/ Gregory D. Vacca
		Gregory D. Vacca President and CEO

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date:		November 1, 2007
		WiFiMed Holdings Company, Inc.
		Registrant
By:		/s/ Gregory Vacca
		President

Filing Compare · WIFIMED HOLDINGS COMPANY, INC.